Bellevue Group Ag Eli Lilly & CO Transaction History

Bellevue Group Ag

$5.93 Billion
Q3 2024

A detailed history of Bellevue Group Ag transactions in Eli Lilly & CO stock. As of the latest transaction made, Bellevue Group Ag holds 44,246 shares of LLY stock, worth $33.3 Million. This represents 0.66% of its overall portfolio holdings.

Number of Shares

44,246

Previous 49,674 10.93%

Holding current value

$33.3 Million

Previous $45 Million 12.84%

% of portfolio

0.66%

Previous 0.75%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $4.19 Million - $5.21 Million	-5,428 Reduced 10.93%	44,246 $39.2 Million
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $6.01 Million - $7.54 Million	-8,291 Reduced 14.3%	49,674 $45 Million
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $1.04 Million - $1.39 Million	1,753 Added 3.12%	57,965 $45.1 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $13.3 Million - $15.7 Million	-25,329 Reduced 31.06%	56,212 $32.8 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $5.92 Million - $8.16 Million	-13,614 Reduced 14.31%	81,541 $43.8 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $29.6 Million - $39.6 Million	84,391 Added 784.01%	95,155 $44.6 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $90,393 - $106,162	-291 Reduced 2.63%	10,764 $3.7 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $503,225 - $586,358	1,565 Added 16.49%	11,055 $4.04 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $2.53 Million - $2.88 Million	8,521 Added 879.36%	9,490 $3.07 Million
Q2 2022 Aug 11, 2022	BUY	$278.73 - $327.27 $270,089 - $317,124	969 New	969 $314,000
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $1.77 Million - $2.2 Million	-7,552 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$224.85 - $279.04 $1.7 Million - $2.11 Million	7,552 New	7,552 $2.09 Million
Q1 2018 May 09, 2018	SELL	$74.21 - $87.6 $17.9 Million - $21.1 Million	-241,262 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $4.64 Million - $5.15 Million	60,189 Added 33.24%	241,262 $20.6 Million
Q2 2017 Aug 14, 2017	BUY	N/A	181,073	181,073 $14.9 Million

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $716B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.

Account

Bellevue Group Ag Eli Lilly & CO Transaction History